17.06.2013 Views

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ESU Courses, 17 March<br />

ESU Course 14<br />

12.00 - 14.00 Surgical management of locally advanced and metastatic renal cancer<br />

Green Hall 2 - Level N-1<br />

Chair: M. Kuczyk, Hanover (DE)<br />

State of the art regarding systemic treatment of matastasized renal cancer<br />

S. Osanto, Leiden (NL)<br />

Surgical options for metastasized renal cell cancer<br />

M. Kuczyk, Hanover (DE)<br />

Surgical treatment of locally advanced renal cell cancer<br />

A. Bex, Amsterdam (NL)<br />

Aims and objectives<br />

Although most renal cancers are small and incidentally found, a significant proportion of patients still present<br />

with locally advanced or even metastatic renal cell carcinoma (RCC) at first diagnosis or develop metastatic<br />

spread during the further course of the disease.<br />

RCC is a unique disease where we had important developments in the last 2 decades both in surgical as<br />

well as nonsurgical and systemic therapies. Although we have now at least 7 drugs with proven efficacy in<br />

metastatic RCC, surgery still remains the only curative therapy.<br />

The first aim of this course is to highlight the role of surgery versus a conservative therapeutic approach.<br />

The efficacy of metastasectomy, for example, will be weighed against that of a medical treatment that is<br />

mainly based on anti – VEGF – directed agents. In addition, new therapeutic concepts including neoadjuvant<br />

treatment upfront surgery for locally advanced disease including patients with intracaval thrombosis will be<br />

highlighted.<br />

Surgery for locally advanced disease particularly in patients with vena caval thrombus is a challenging<br />

situation and tips and tricks of this type of surgery including the clinical results that can be achieved by<br />

an aggressive surgical management will be indicated. And finally, the place of cytoreductive nephrectomy<br />

during the treatment of metastatic RCC and the role of surgery for the treatment of locally recurrent disease<br />

will be discussed.<br />

This course is an excellent opportunity to learn what the urologist can offer to renal cancer patients with<br />

difficult tumours and metastatic RCC. The course is an ideal opportunity for all; residents, the practicing<br />

urologist and the oncologic urologist. Don’t miss this course if you see patients with advanced RCC in your<br />

practice!<br />

Registration fee excluding VAT<br />

<strong>EAU</strong> members € 32<br />

Non-<strong>EAU</strong> members € 47<br />

Residents (members/non-members) € 21<br />

<strong>EAU</strong> Milan <strong>2013</strong><br />

337<br />

ESU Courses

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!